Theravance Biopharma Aktie
11,90
EUR
+0,10
EUR
+0,85
%
14,07
USD
+0,29
USD
+2,10
%
Werbung
Theravance Biopharma Aktie Analyse
| 16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
| 11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
| 21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC | |
| 12.10.16 | Theravance Biopharma Underperform | Robert W. Baird & Co. Incorporated | |
| 03.02.15 | Theravance Biopharma Neutral | Robert W. Baird & Co. Incorporated |
Werbung
Werbung